The role of the circadian clock in cancer hallmark acquisition and immune-based cancer therapeutics.

Cash, Elizabeth; Sephton, Sandra; Woolley, Cassandra; Elbehi, Attia M; R I, Anu; Ekine-Afolabi, Bene; Kok, Victor C

Cash, Elizabeth; Sephton, Sandra; Woolley, Cassandra; Elbehi, Attia M; R I, Anu; Ekine-Afolabi, Bene; Kok, Victor C.

Afiliación

Cash E; Department of Otolaryngology and Communicative Disorders, University of Louisville School of Medicine, James Graham Brown Cancer Center, 529 S Jackson Street, Louisville, KY, 40202, USA. Liz.cash@louisville.edu.
Sephton S; Department of Psychological & Brain Sciences, University of Louisville, Louisville, KY, USA.
Woolley C; Department of Microbiology and Immunology, University of Louisville School of Medicine, Louisville, KY, USA.
Elbehi AM; Department of Oncology, Medical Sciences Division, University of Oxford, Oxford, UK.
R I A; Department of Clinical Biochemistry, MVR Cancer Center and Research Institute, Kerala, India.
Ekine-Afolabi B; ZEAB Therapeutic Ltd, London, UK.
Kok VC; Department of Health, Sport & Bioscience, University of East London, Stratford, UK.

J Exp Clin Cancer Res ; 40(1): 119, 2021 Apr 01.

Article en En | MEDLINE | ID: mdl-33794967

Asunto(s)

Relojes Circadianos/inmunología; Inmunoterapia/métodos; Neoplasias/terapia; Humanos; Neoplasias/inmunología

Palabras clave

Cancer; Circadian; Clock gene; Glucocorticoid; Immune checkpoint inhibitor; Immuno-oncology

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Relojes Circadianos / Inmunoterapia / Neoplasias Límite: Humans Idioma: En Revista: J Exp Clin Cancer Res Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google